Where we are with point-of-care testing

Can We Apply the Control Material from Standard Clinical Chemistry Analyzer for Usage in the Point of Care Testing Analyzer?

How Much Can We Save the Cost from Shifting from Single - Test Strip to Multiple - Test Strip in Point of Care Testing Analysis for Common Clinical Chemistry Parameters ?

I-36: Preimplantation Genetic Diagnosis - Where Have We Been and Where Are We Going

Preimplantation genetic diagnosis (PGD) is now considered routine in IVF laboratories with micromanipulation capability and access to genetic diagnostic services. The past two decades have witnessed a dramatic increase in the use of PGD, the number of cycles performed, and the indications for which PGD has been used. This increase has been mirrored by a slow, but steady, increase in the range o...

Field effect transistor nanobiosensors: State-of-the-art and key challenges as point of care testing devices

The existing health care systems focus on treating diseases rather than preventing them. Patients are generally not tested unless physiological symptoms are appeared. When they do get tested, the results often take several days and can be inconclusive if the disease is at an early stage. In order to facilitate the diagnostics process and make tests more readily available for patients, the conce...

Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

TESTING FOR “RANDOMNESS” IN SPATIAL POINT PATTERNS, USING TEST STATISTICS BASED ON ONE-DIMENSIONAL INTER-EVENT DISTANCES

To test for “randomness” in spatial point patterns, we propose two test statistics that are obtained by “reducing” two-dimensional point patterns to the one-dimensional one. Also the exact and asymptotic distribution of these statistics are drawn.